AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

AJPH First Look, published online ahead of print Feb 28, 2007
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
AJPH.2005.072264v1
97/4/641    most recent
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farris, R. P.
Right arrow Articles by Finkelstein, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farris, R. P.
Right arrow Articles by Finkelstein, E. A.
Related Collections
Right arrow Prevention
Right arrow Public Health Practice
Right arrow Cardiovascular Disease
April 2007, Vol 97, No. 4 | American Journal of Public Health 641-647
© 2007 American Public Health Association
DOI: 10.2105/AJPH.2005.072264

HEALTH POLICY AND ETHICS

Beyond Effectiveness: Evaluating the Public Health Impact of the WISEWOMAN Program

Rosanne P. Farris, PhD, Julie C. Will, PhD, Olga Khavjou, MA and Eric A. Finkelstein, PhD

Rosanne P. Farris and Julie C. Will are with the Centers for Disease Control and Prevention, Division for Heart Disease and Stroke Prevention, Atlanta, Ga. Olga Khavjou and Eric A. Finkelstein are with RTI International, Health, Social, and Economics Research, Research Triangle Park, NC.

Correspondence: Requests for reprints should be sent to Rosanne P. Farris, PhD, Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, 4770 Buford Highway, MS K-47 Atlanta, GA 30341 (e-mail: rif6{at}cdc.gov).

Interventions that are effective are often improperly or only partially implemented when put into practice. When intervention programs are evaluated, feasibility of implementation and effectiveness need to be examined. Reach, effectiveness, adoption, implementation, and maintenance make up the RE-AIM framework used to assess such programs. To examine the usefulness of this metric, we addressed 2 key research questions. Is it feasible to operationalize the RE-AIM framework using women’s health program data? How does the determination of a successful program differ if the criterion is (1) effectiveness alone, (2) reach and effectiveness, or (3) the 5 dimensions of the RE-AIM framework? Findings indicate that it is feasible to operationalize the RE-AIM concepts and that RE-AIM may provide a richer measure of contextual factors for program success compared with other evaluation approaches.




This article has been cited by other articles:


Home page
 AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
L. Terre
Health Risk Reduction in Women
American Journal of Lifestyle Medicine, June 1, 2008; 2(3): 227 - 229.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Public Health Association